RT Journal Article
SR Electronic
T1 Adherence to methotrexate and associated factors considering social desirability in patients with rheumatoid arthritis: a multicenter cross-sectional study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.08.24.22279163
DO 10.1101/2022.08.24.22279163
A1 Yajima, Nobuyuki
A1 Kawaguchi, Takashi
A1 Takahashi, Ryo
A1 Nishiwaki, Hiroki
A1 Toyoshima, Yoichi
A1 Oh, Koei
A1 Odai, Tsuyoshi
A1 Kanai, Takayuki
A1 Morisky, Donald E.
A1 Yamaguchi, Takuhiro
A1 Kasama, Tsuyoshi
YR 2022
UL http://medrxiv.org/content/early/2022/08/25/2022.08.24.22279163.abstract
AB Background Assessing medication adherence in rheumatoid arthritis (RA) is clinically significant as low adherence is associated with high disease activity. Self-reported medication adherence surveys have been shown to have problems with overestimation of adherence due to social desirability bias. However, no MTX adherence studies adjusted for social desirability have been conducted to date. This study aimed to evaluate adherence to MTX and perform an investigatory search for factors associated with MTX adherence including social desirability.Methods This cross-sectional multicenter study was conducted among adult RA patients consuming oral MTX for ≥3 months. We examined the distribution of MTX adherence, according to the eight-item Morisky Medication Adherence Scale (MMAS-8). Furthermore, an exploratory factor analysis involving social desirability was examined to identify factors associated with MTX adherence using linear regression analysis. To deal with missing values, we used multiple imputations with chained equations methods.Results A total of 165 RA patients were enrolled. The median age was 64 years, and 86.1% were women. Based on the MMAS-8, low, medium, and high adherences were noted in 12.1%, 60.0%, and 27.9% of participants, respectively. High social desirability (coefficient, 0.14; 95% confidence interval [CI], 0.05–0.23; p<0.05) and high age (coefficient per 10 years, 0.16; 95% CI, 0.01–0.03; p<0.05) were associated with high MTX adherence, whereas full-time work was negatively associated with high MTX adherence (coefficient, -0.50; 95% CI, -0.95–-0.05; p<0.05).Conclusions Sixty percent of RA patients had medium adherence to MTX. High social desirability, high educational level, and non-full-time work may be associated with high MTX adherence. Physicians should confirm MTX adherence before switching or adding disease-modifying anti-rheumatic drugs in cases of uncontrolled disease activity.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The ethics committee of Showa University Hospital (approval number 1446) and Showa University Toyosu Hospital, Showa University Northern Yokohama Hospital, Kanto Rosai Hospital approved this study, and informed consent was obtained from all participants before study enrolment.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe dataset analyzed in this paper is available from the corresponding author on reasonable request.ADLActivities of Daily LivingBMQBeliefs about Medicines QuestionnaireBPIBrief Pain InventoryCES-DCenter for Epidemiological Studies DepressionDAS28-ESRDisease Activity Score (28 joint count)-erythrocyte sedimentation rateDMARDsdisease-modifying antirheumatic-drugsMCSmental component summarymHAQmodified Health Assessment QuestionnaireMMAS-8Morisky Medication Adherence Scale MTX: methotrexateNRSNumerical Rating ScalePCSphysical component summaryRArheumatoid arthritisSDSSocial Desirability ScaleSF-88-item Short-Form Health Survey